Latest Breaking News On - Transverse medical inc - Page 1 : comparemela.com

Unveiling Growth Trends in the 14% CAGR TAVR Embolic Protection Market

Transverse Medical Appoints David C. Blowers to Board of Directors, Dr. Rahul Sharma as Independent Member, Carl St. Bernard rejoins Board.

TAVR Embolic Protection Market to Reach $405.4 Million, Globally, by 2032 at 14% CAGR: Allied Market Research

/PRNewswire/ Allied Market Research published a report, titled, "TAVR Embolic Protection Market by Product (SENTINEL cerebral protection system, TriGUARD 3.

Boulder iQ Names Larry Blankenship as Director, Helping Life Sciences Companies with Product Development

Global Embolic Protection Devices Market Is Expected to Reach USD 1875.91 million by 2027 : Fior Markets

in 2019 The product segment includes distal filters, proximal occlusion filters and distal occlusion filters. The distal filters segment held the highest share of 38.50% in 2019 in the embolic protection devices market. It is due to non-interference with lesion visualization, the ease of use provided by these devices, and the availability of these filters in various specifications. The cardiovascular diseases segment dominated the market and valued at USD 375.11 million in the year 2019 The application segment includes peripheral vascular diseases, cardiovascular diseases and neurovascular diseases. Cardiovascular diseases held the highest share of USD 375.11 million in 2019 in the application segment. These are predominantly utilized in cardiovascular procedures, followed by Peripheral Vascular Diseases (PVDs). It is due to the growing geriatric population. The pervasiveness of Cardiovascular Diseases (CVDs) is set to follow an upward inclination to serve the market as cardiova